Previous 10 | Next 10 |
Ardelyx to Present at the Jefferies 2021 Virtual Healthcare Conference PR Newswire FREMONT, Calif. and WALTHAM, Mass. , May 25, 2021 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-in-clas...
These Current & Former Penny Stocks Are Making Their Mark In 2021 Penny stocks have been a big focus for retail traders over the last few years. In fact, if you look at any of the top small-cap stock ETFs, the trend is clear right now. Since the depths of the pandemic drop, the Russ...
ARDX had a PDUFA on April 29, which got delayed by three months because the FDA wants to review new analyses it requested. This has brought the stock down. However, there seems to be no thesis disruption here. For further details see: Ardelyx: Second Opportunity
Ardelyx (ARDX): Q1 GAAP EPS of -$0.34 misses by $0.01.Revenue of $6.58M (+443.8% Y/Y) beats by $5.48M.Press Release For further details see: Ardelyx EPS misses by $0.01, beats on revenue
Ardelyx Reports First Quarter 2021 Financial Results and Recent Business Highlights PR Newswire FREMONT, Calif. and WALTHAM, Mass. , May 6, 2021 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on developing innovative first-...
Shares of Ardelyx (NASDAQ: ARDX) were sinking 13% lower as of 11 a.m. EDT on Friday. The decline came after the company announced Thursday evening that the U.S. Food and Drug Administration (FDA) is pushing back its review period for tenapanor by three months. Ardelyx originally...
Gainers: Brooklyn ImmunoTherapeutics (BTX) +38%, Motus GI MOTS +32%, CryoLife (CRY) +16%, Mesoblast MESO +14%, Arcutis Biotherapeutics (ARQT) +10%.Losers: Ardelyx (ARDX) -13%, Pacific Biosciences of California (PACB) -13%, ALX Oncolo...
MicroVision (MVIS) -24% on Q1 earnings release.Ardelyx (ARDX) -18% after tenapanor PDUFA extension.Twitter (TWTR) -13% on Q1 earnings release.Eros STX Global (ESGC) -11%.CPS Technologies (CPSH) -10% on Q1 earnings release.Brooklyn ImmunoTherapeutics (BT...
Gainers: [[LAUR]] +14.2%. [[TEAM]] +7.5%. [[FIVN]] +7.3%. [[TXRH]] +6.1%. [[XERS]] +5.7%.Losers: [[ARDX]] -16.8%. [[MVIS]] -16.8%. [[SWKS]] -7.3%. [[MRKR]] -5.6%. [[LLNW]] -4.9%. For further details see: SWKS, TEAM, MVIS and FIVN among after-hours movers
Ardelyx (ARDX) shares slide more than 19% during post-market trading after announcing that the Prescription Drug User Fee Act ((PDUFA)) date for tenapanor for the control of serum phosphorus in adult patients with chronic kidney disease ((CKD)) on dialysis has been extende...
News, Short Squeeze, Breakout and More Instantly...
Why The Stock Market Is Down Today Why is the stock market down today? The final week of June and the second quarter has been jam-packed with economic data and inflation-related events. Fed Chair Jerome Powell recently said that the global economy has entered a “new world”...
Ardelyx Announces $20 Million Financing Agreement with HealthCare Royalty Partners PR Newswire HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA ® in the United States in exchange for future hyperphosphatemia royalty payments from ...
Ardelyx Announces FDA Advisory Committee Meeting to Review XPHOZAH® NDA Tentatively Scheduled for November 16, 2022 PR Newswire WALTHAM, Mass. , June 21, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a missio...